Cargando…

Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors

Dopamine controls diverse behaviors and their dysregulation contributes to many disorders. Our ability to understand and manipulate the function of dopamine is limited by the heterogenous nature of dopaminergic projections, the diversity of neurons that are regulated by dopamine, the varying distrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Donthamsetti, Prashant, Winter, Nils, Hoagland, Adam, Stanley, Cherise, Visel, Meike, Lammel, Stephan, Trauner, Dirk, Isacoff, Ehud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346604/
https://www.ncbi.nlm.nih.gov/pubmed/34362914
http://dx.doi.org/10.1038/s41467-021-25003-w
_version_ 1783734911926009856
author Donthamsetti, Prashant
Winter, Nils
Hoagland, Adam
Stanley, Cherise
Visel, Meike
Lammel, Stephan
Trauner, Dirk
Isacoff, Ehud
author_facet Donthamsetti, Prashant
Winter, Nils
Hoagland, Adam
Stanley, Cherise
Visel, Meike
Lammel, Stephan
Trauner, Dirk
Isacoff, Ehud
author_sort Donthamsetti, Prashant
collection PubMed
description Dopamine controls diverse behaviors and their dysregulation contributes to many disorders. Our ability to understand and manipulate the function of dopamine is limited by the heterogenous nature of dopaminergic projections, the diversity of neurons that are regulated by dopamine, the varying distribution of the five dopamine receptors (DARs), and the complex dynamics of dopamine release. In order to improve our ability to specifically modulate distinct DARs, here we develop a photo-pharmacological strategy using a Membrane anchored Photoswitchable orthogonal remotely tethered agonist for the Dopamine receptor (MP-D). Our design selectively targets D1R/D5R receptor subtypes, most potently D1R (MP-D1(ago)), as shown in HEK293T cells. In vivo, we targeted dorsal striatal medium spiny neurons where the photo-activation of MP-D1(ago) increased movement initiation, although further work is required to assess the effects of MP-D1(ago) on neuronal function. Our method combines ligand and cell type-specificity with temporally precise and reversible activation of D1R to control specific aspects of movement. Our results provide a template for analyzing dopamine receptors.
format Online
Article
Text
id pubmed-8346604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83466042021-08-20 Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors Donthamsetti, Prashant Winter, Nils Hoagland, Adam Stanley, Cherise Visel, Meike Lammel, Stephan Trauner, Dirk Isacoff, Ehud Nat Commun Article Dopamine controls diverse behaviors and their dysregulation contributes to many disorders. Our ability to understand and manipulate the function of dopamine is limited by the heterogenous nature of dopaminergic projections, the diversity of neurons that are regulated by dopamine, the varying distribution of the five dopamine receptors (DARs), and the complex dynamics of dopamine release. In order to improve our ability to specifically modulate distinct DARs, here we develop a photo-pharmacological strategy using a Membrane anchored Photoswitchable orthogonal remotely tethered agonist for the Dopamine receptor (MP-D). Our design selectively targets D1R/D5R receptor subtypes, most potently D1R (MP-D1(ago)), as shown in HEK293T cells. In vivo, we targeted dorsal striatal medium spiny neurons where the photo-activation of MP-D1(ago) increased movement initiation, although further work is required to assess the effects of MP-D1(ago) on neuronal function. Our method combines ligand and cell type-specificity with temporally precise and reversible activation of D1R to control specific aspects of movement. Our results provide a template for analyzing dopamine receptors. Nature Publishing Group UK 2021-08-06 /pmc/articles/PMC8346604/ /pubmed/34362914 http://dx.doi.org/10.1038/s41467-021-25003-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Donthamsetti, Prashant
Winter, Nils
Hoagland, Adam
Stanley, Cherise
Visel, Meike
Lammel, Stephan
Trauner, Dirk
Isacoff, Ehud
Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
title Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
title_full Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
title_fullStr Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
title_full_unstemmed Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
title_short Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
title_sort cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346604/
https://www.ncbi.nlm.nih.gov/pubmed/34362914
http://dx.doi.org/10.1038/s41467-021-25003-w
work_keys_str_mv AT donthamsettiprashant cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT winternils cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT hoaglandadam cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT stanleycherise cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT viselmeike cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT lammelstephan cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT traunerdirk cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors
AT isacoffehud cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors